Monday, 16 November 2026LatestVideosAboutContact
Latest
Jio In Talks With ISRO, Skyroot For 1,600-Satellite Constellation: ReportIndia, US, eight other nations sign declaration to safeguard AI supply chainsPLI schemes show gains, but job creation lags; electronics leads, battery manufacturing struggles: NITI AayogHyderabad builders pay thrice more for water amid borewell curbsMan held over morphed Sonakshi Sinha pics releasedBitcoin options traders brace for slide to $60,000 after selloffRobert Pattinson Emerges As James Bond Frontrunner With A Three-Film Deal: ReportHow Nvidia’s export-banned Blackwell chips are showing up in Chinese AI modelsJay Shah reappointed unopposed as ICC Chair for second termDidn't do it for money: Usman Khawaja defends Sandpapergate revelations in his book[Update] SBI Data Breach: FIR Filed Over Alleged Theft Of 3.75 Lakh Bank RecordsMossad killed Iranian general in hunt for missing Israeli airman
BusinessUpdated 25 min ago

Glenmark launches generic Inlyta tablets for kidney cancer treatment in US

Image: Business Standard

Glenmark Axitinib tablets (a generic equivalent to Pfizer's Inlyta) are used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer

Continue reading on Business Standard

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all